ASMS

UB Community Development, a subsidiary of United Bancorporation of Alabama, Inc., Announces $12.5 Million in New Markets Tax Credit Funds to Alabama School of Mathematics and Science.

Retrieved on: 
Thursday, March 30, 2023
State, Partnership, UB, Education, ASMS, Humanities, Research, Alabama School of Mathematics and Science, Employment Development Department, NMTC, Student, Admission, New Markets Tax Credit Program, Engineering, Leadership Academy, United Bank, Tutoring, Nursing, Science, Mathematics, STEM

As we look to the next 30 years for our school, a new science building and research facility is essential to achieving our strategic plan.

Key Points: 
  • As we look to the next 30 years for our school, a new science building and research facility is essential to achieving our strategic plan.
  • We are deeply grateful for the time and investment of the UB Community Development team in making this new building possible for ASMS.
  • "ASMS serves high school students from across the State of Alabama at no cost to them or their families," stated Alex Jones, President of UB Community Development.
  • This camp offers a creative learning opportunity for over 1,200 students from across the State in 7th through 9th grades each summer.

COPA HOLDINGS ANNOUNCES MONTHLY TRAFFIC STATISTICS FOR FEBRUARY 2023

Retrieved on: 
Friday, March 10, 2023
Copa Holdings, COVID-19, ASMS, Revolutions per minute, Statistics, Airline

Available seat miles - represents the aircraft seating capacity multiplied by the number of miles the seats are flown.

Key Points: 
  • Available seat miles - represents the aircraft seating capacity multiplied by the number of miles the seats are flown.
  • Given the irregular nature of the Company's operations starting in March 2020 due to the Covid-19 pandemic, we are comparing this traffic report to 2019 statistics.
  • Consolidated capacity (ASMs) came in 2.6% higher than in February 2019, while passenger traffic (RPMs) increased by 5.4%.
  • Copa Holdings is a leading Latin American provider of passenger and cargo services.

New platform set to accelerate early-stage targeted protein degradation programmes

Retrieved on: 
Thursday, March 9, 2023
Protein, DEL, DMPK, Chemistry, IND, ASMS, ChromeOS, Triage, Drug discovery, Ligase, TPD, Biology, Ligand, ADME, PROTAC, Pharmaceutical industry, Palladium, Fine chemical

Developed in-house at Sygnature Discovery, CHARMED is a technology platform designed to accelerate and support early-stage targeted protein degradation (TPD) programmes.

Key Points: 
  • Developed in-house at Sygnature Discovery, CHARMED is a technology platform designed to accelerate and support early-stage targeted protein degradation (TPD) programmes.
  • Dr Roland Hjerpe is Senior Principal Scientist, Bioscience at Sygnature Discovery and leads the targeted protein degradation work.
  • He says: "In most cases, targeted protein degradation relies on bringing a ubiquitin ligase into close proximity with a target protein.
  • The platform provides a quick way to collect data and triage a large number of molecules into a smaller set.

Air Canada Reports Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Friday, February 17, 2023
Available seat miles, Atmosphere of Earth, Air Canada Cargo, Air Canada, CASM, Canada, Weather, EBITDA, News, GAAP, Operating cost, ASM, ASMS, Adjustment, Aeroplan, Growth, Ratio, Environment, Depreciation, Tax, Video game, Arms industry, Cryptocurrency, Bookkeeping, Airline, Car rental

Record fourth quarter passenger revenues of $4.062 billion, doubled than fourth quarter 2021 and about two per cent higher than fourth quarter 2019

Key Points: 
  • Record fourth quarter passenger revenues of $4.062 billion, doubled than fourth quarter 2021 and about two per cent higher than fourth quarter 2019
    Record fourth quarter operating revenues of $4.680 billion, 71 per cent higher than fourth quarter 2021 and about six per cent higher than fourth quarter 2019
    Total liquidity of over $9.8 billion at December 31, 2022
    MONTREAL, Feb. 17, 2023 /CNW/ - Air Canada today reported its fourth quarter and full year 2022 financial results.
  • We reported record fourth quarter passenger and operating revenues, surpassing our results from a year ago and those of the fourth quarter of 2019.
  • Record fourth quarter passenger revenues of $4.062 billion nearly doubled from the fourth quarter of 2021, or about a two per cent increase from the fourth quarter of 2019.
  • Record fourth quarter operating revenues of $4.680 billion increased 71 per cent from the fourth quarter of 2021 and about six per cent from the fourth quarter of 2019.

Allotrope Foundation Further Expands Access to Interoperable Laboratory Data Standards with Public JSON-based Analytical Data Models

Retrieved on: 
Wednesday, February 8, 2023
Organization, Energy Institute, Creative Commons, Mass spectrometry, JavaScript, Allotrope Foundation, Software, Chromatography, Research, ASM, Intelligence, ASMS, FAIR, JSON, Internet, NMR, AFO, Collection, Phosphorus, Allotropy

WASHINGTON, Feb. 8, 2023 /PRNewswire-PRWeb/ -- Allotrope Foundation, an international consortium of chemical & life sciences organizations, is excited to announce the public release of its extensive set of standardized data models that cover over forty different techniques and domains essential to research and development in the analytical laboratory. The data models leverage the modern JavaScript object notation (JSON) format, which is widely used as the backbone of communications for today's internet and immediately familiar to any software engineer or data scientist. The Allotrope Simple Models (ASMs) are designed by thought leaders in Allotrope's diverse community of industry, governmental, and academic institutions to represent a true pan-industry data standard to streamline analytical data processing and accelerate digital transformation in the lab. Designed to be implemented quickly and easily, ASM models capture critical results and parameters essential to accurately capture, preserve, and transfer laboratory data. These models are specifically tailored to meet the exponential growth in the use of bedrock analytical data to fuel artificial intelligence and machine learning techniques and cover diverse techniques such as NMR spectroscopy, chromatography, and mass spectrometry.

Key Points: 
  • Designed to be implemented quickly and easily, ASM models capture critical results and parameters essential to accurately capture, preserve, and transfer laboratory data.
  • The models leverage Allotrope's standardized, open formal vocabulary of terms and definitions commonly used in scientific data and experiments, the Allotrope Foundation Ontologies (AFO).
  • Through the application of reusable modeling patterns, the Allotrope data models make laboratory data interoperable and reusable anywhere ASM is used.
  • For more information on how to access the ASM and licensing terms, please visit the Allotrope Foundation website at https://www.allotrope.org/asm .

Frontier Airlines Reports Fourth Quarter Profit on Strong Revenue and Cost Performance

Retrieved on: 
Wednesday, February 8, 2023
Aircraft, Travel, GAAP, Risk, Public expenditure, ASMS, Airbus, Gasoline, Airline, Airbus A320neo family, Frontier

During the fourth quarter of 2022, Frontier generated 103 ASMs per gallon, four percent higher than the 2019 quarter.

Key Points: 
  • During the fourth quarter of 2022, Frontier generated 103 ASMs per gallon, four percent higher than the 2019 quarter.
  • The A321neo is expected to unlock meaningful scale efficiencies by way of fuel savings and higher average seats per departure.
  • As of December 31, 2022, over 70 percent of future committed aircraft deliveries, including direct leases, are for A321neo aircraft.
  • The first quarter 2023 and full-year 2023 guidance provided below is based on the Company's current estimates and is not a guarantee of future performance.

Sun Country Airlines Reports Fourth Quarter and Full Year 2022 Results

Retrieved on: 
Thursday, February 2, 2023
Aircraft, Continental Airlines, Amazon, GAAP, Caesars Entertainment, ASMS, Sun Country Airlines, Rail transport by country, OH, CASM, CO, Essential Air Service, Communication, Ecolab, Minneapolis–Saint Paul International Airport, Adjustment, MSP, Transport, Growth, ASR, U.S. Department of Defense Strategy for Operating in Cyberspace, Aviation, Airline, Management, Microbial contamination of diesel fuel

MINNEAPOLIS, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Sun Country Airlines Holdings, Inc. (“Sun Country Airlines,” “Sun Country,” the “Company”) (NASDAQ: SNCY) today reported financial results for its fourth quarter and full year ended December 31, 2022.

Key Points: 
  • For the fourth quarter of 2022, the Company reported total revenue of $227.2 million, which was 31.6% more than the fourth quarter of 2021.
  • The fourth quarter 2022 total fare of $177 exceeded fourth quarter 2021 by 14% while scheduled load factor increased 7.8 percentage points to 84.4%.
  • In the fourth quarter of 2022, cargo revenue was $24.4 million, a 4.6% increase versus the fourth quarter of 2021.
  • Adjusted CASM(1) in the fourth quarter increased 7.1% versus the fourth quarter 2021 mostly driven by the new pilot agreement that was signed at the end of 2021.

Cenobamate (ONTOZRY®), for the Treatment of Uncontrolled Focal-onset Seizures in Adults, Is Now Available in France and Belgium

Retrieved on: 
Wednesday, December 7, 2022
Science, Other Science, Biotechnology, Research, Pharmaceutical, Health, Mental Health, Other Health, Pharma, Lancet, Safety, Patient, ASMS, European Medicines Agency, History, Seizure, Pharmaceutical industry

Angelini Pharma is committed to helping patients in the therapeutic areas of Brain Health and Consumer Healthcare.

Key Points: 
  • Angelini Pharma is committed to helping patients in the therapeutic areas of Brain Health and Consumer Healthcare.
  • In January 2021, Angelini Pharma announced that they concluded a definitive merger agreement under which Angelini Pharma acquired Arvelle Therapeutics.
  • Cenobamate is a novel small molecule that provides a dual, complementary mechanism of action aimed at treatment of seizures.
  • Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicenter, double-blind, randomized, placebo-controlled, dose-response trial.

Orlando's Most Loved Animal, SEA LIFE Aquarium Orlando's Ted the Turtle, Makes Debut on New Frontier Airlines Plane Tail

Retrieved on: 
Tuesday, December 6, 2022
Travel, Water, Sea, Social media, Aircraft, Den, Ted, TED, Airbus, Michelin, Frontier Airlines, Turtle excluder device, Calendar, Central Florida Zoo and Botanical Gardens, Sea turtle, Shark, Partnership, Sale, Airbus A320neo family, Animal, Turtle, MCO, DIVE, Orlando International Airport, A320, Seaweed, Nonstop Liberal Arts Institute, Survival, Multimedia, SEA, Nature, Education, Friends, Tourism, ULCC, Marketing, Loggerhead sea turtle, ASMS, Amusement park, Airline, Frontier, Central Florida

ORLANDO, Fla., Dec. 6, 2022 /PRNewswire/ -- Frontier Airlines unveiled a new plane at Orlando International Airport (MCO) featuring SEA LIFE Orlando Aquarium's Ted the Turtle on Monday. Together with Visit Orlando, SEA LIFE Orlando and Frontier Airlines partnered for an in-terminal flight celebration to promote animal conservation and visitation to the Orlando region.

Key Points: 
  • Together with Visit Orlando, SEA LIFE Orlando and Frontier Airlines partnered for an in-terminal flight celebration to promote animal conservation and visitation to the Orlando region.
  • "We're thrilled to welcome Ted the Loggerhead Sea Turtle to our fleet," said Tyri Squyres, vice president of marketing at Frontier Airlines.
  • "SEA LIFE Orlando is excited to partner with Frontier on this amazing opportunity," said Kayla Cristell, lead aquarist at SEA LIFE Orlando Aquarium.
  • "It's a unique honor for Ted, our beloved SEA Turtle, to be recognized as Orlando's most loved animal.

Xenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2022)

Retrieved on: 
Friday, December 2, 2022
Dravet syndrome, ASMS, Epilepsy, COVID-19, Safety, MPC, Music City Center, National Primate Research Exhibition Hall, Science, OLE, Urinary retention, Outline, Research, Clinical trial, American Epilepsy Society, Therapy, Convention, Poster, DBP, Patient, Disease, Security (finance), Annual general meeting, FOS, AES, Efficacy, Seizure, KCNQ2, EPIK, SD, Drug Quality and Security Act, Pharmaceutical industry, Medical imaging, Xenon

BURNABY, British Columbia, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced it will provide updates on its proprietary, neurology programs at the Annual Meeting of the American Epilepsy Society (AES 2022). In addition, the Company is presenting results from the open label extension (OLE) and sub-analyses of data from the XEN1101 Phase 2b X-TOLE clinical trial.

Key Points: 
  • Mr. Ian Mortimer, Xenons President and Chief Executive Officer stated, We continue to advance our portfolio of neurology-focused programs.
  • We also look forward to meeting with leading epileptologists, including Xenon trial investigators, as well as patient advocacy groups at this important meeting.
  • We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy.
  • Xenon and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions.